Proteome SciencesPMSNF Market Cap is $7.80 Mil as of Jun. 26, 2026. The stock has 6 warning signs investors should review. Among 219 Medical Diagnostics & Research companies, Proteome Sciences ranks worse than 85.39% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Proteome Sciences's share price for the quarter that ended in Dec. 2025 was $0.03825. Proteome Sciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 295.18 Mil. Therefore, Proteome Sciences's market cap for the quarter that ended in Dec. 2025 was $11.29 Mil.
Proteome Sciences's quarterly market cap
declined
from Dec. 2024 ($15.08 Mil) to Jun. 2025 ($13.25 Mil) and
declined
from Jun. 2025 ($13.25 Mil) to Dec. 2025 ($11.29 Mil).
Proteome Sciences's annual market cap
increased
from Dec. 2023 ($7.38 Mil) to Dec. 2024 ($15.08 Mil) but then
declined
from Dec. 2024 ($15.08 Mil) to Dec. 2025 ($11.29 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Proteome Sciences's Enterprise Value for Today is $27.53 Mil.
Proteome Sciences (OTCPK:PMSNF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Proteome Sciences Market Cap Related Terms
Proteome Sciences Market Cap Historical Data
* Premium members only.
The historical data trend for Proteome Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Proteome Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proteome Sciences Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Proteome Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Proteome Sciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteome Sciences (PMSNF) has a Market Cap of $7.80 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Proteome Sciences and its competitors. According to the industry distribution chart, Proteome Sciences ranks #187 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 85.4%.
Is Proteome Sciences' Market Cap too high?
Proteome Sciences' current Market Cap is $7.80 Mil. The Medical Diagnostics & Research industry median Market Cap is 55.76. Proteome Sciences' value of $7.80 Mil is 86% below this industry median. Based on the distribution chart, Proteome Sciences ranks #187 out of 219 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Proteome Sciences' Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Proteome Sciences ranks #187 out of 219 companies for Market Cap. This places Proteome Sciences in the lower half of its industry. The industry median Market Cap is 55.76. Proteome Sciences' value of $7.80 Mil is 86% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 55.76, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Proteome Sciences's current Market Cap of $7.80 Mil is 86% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Proteome Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 55.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proteome Sciences's current Market Cap is $7.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Proteome Sciences (PMSNF) has a current Market Cap of $7.80 Mil. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 17.5% below its estimated fair value. The current Market Cap is $7.80 Mil and 86% below the Medical Diagnostics & Research industry median of 55.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current Market Cap is $7.80 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMSNF has been successfully added to your 